Celebrex and Feeding disorder - a phase IV clinical study of FDA data
Feeding disorder is found among people who take Celebrex, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Celebrex and have Feeding disorder. It is created by eHealthMe based on reports of 137,119 people who have side effects when taking Celebrex from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
137,119 people reported to have side effects when taking Celebrex.
Among them, 113 people (0.08%) have Feeding disorder.
What is Celebrex?
Celebrex has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 140,532 Celebrex users for its effectiveness, alternative drugs and more.
What is Feeding disorder?
Feeding disorder (when children refuse to eat certain food groups) is found to be associated with 1,332 drugs and 823 conditions by eHealthMe.
Number of Celebrex and Feeding disorder reports submitted per year:
Time on Celebrex when people have Feeding disorder *:
Gender of people who have Feeding disorder when taking Celebrex*:
Age of people who have Feeding disorder when taking Celebrex *:
Common drugs people take besides Celebrex *:
Common side effects people have besides Feeding disorder *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Celebrex and have Feeding disorder?Check whether Feeding disorder is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Feeding disorder and when was it recovered:
Expand to all the drugs that have ingredients of celecoxib:
Alternative drugs to, pros and cons of Celebrex:
- Celebrex (140,532 reports)
Common Celebrex side effects:
- Drug ineffective: 16,713 reports
- Pain: 13,601 reports
- Joint pain: 10,756 reports
- Heart attack: 9,103 reports
- Fatigue (feeling of tiredness): 9,070 reports
- High blood pressure: 7,329 reports
Browse all side effects of Celebrex:a b c d e f g h i j k l m n o p q r s t u v w x y z
Feeding disorder treatments and more:
- Feeding disorder (15,001 reports)
COVID vaccines that are related to Feeding disorder:
- Feeding disorder in Moderna COVID Vaccine
- Feeding disorder in Pfizer BioNTech Covid Vaccine
- Feeding disorder in Johnson and Johnson Covid Vaccine
Common drugs associated with Feeding disorder:
- Aspirin: 858 reports
- Methotrexate: 782 reports
- Humira: 759 reports
- Prednisone: 758 reports
- Enbrel: 556 reports
- Omeprazole: 535 reports
- Tramadol: 509 reports
- Vitamin d: 503 reports
- Gabapentin: 480 reports
- Metformin: 441 reports
All the drugs that are associated with Feeding disorder:
- Feeding disorder (1,332 drugs)
Common conditions associated with Feeding disorder:
- Rheumatoid arthritis: 916 reports
- Pain: 701 reports
- Multiple sclerosis: 646 reports
- High blood pressure: 634 reports
- Crohn's disease: 472 reports
- Depression: 386 reports
- Diabetes: 361 reports
All the conditions that are associated with Feeding disorder:
- Feeding disorder (823 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celebrex) and Celebrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hypokalemia and Weight Decreased - 3 seconds ago
- Vesicare and Nasal Congestion - 8 seconds ago
- Platinol and Body Temperature Increased - 8 seconds ago
- Pilocarpine Hydrochloride and Clotrimazole drug interaction - 15 seconds ago
- Testoderm and Hearing Loss - 16 seconds ago
- Duodenal Ulcer Aggravated and Mean Cell Haemoglobin Concentration Abnormal - 18 seconds ago
- Dermatitis Atopic Aggravated and Speech Impairment (Adult) - 19 seconds ago
- Chronic Phase Chronic Myeloid Leukaemia and Nosebleed - 21 seconds ago
- Epipen and Anticonvulsant Drug Level Decreased - 21 seconds ago
- Guaifenesin and Failure To Thrive - 23 seconds ago